Show simple item record

dc.contributor.authorRahim, Nicole Aliya
dc.date.accessioned2013-04-11T19:13:26Z
dc.date.available2013-04-11T19:13:26Z
dc.date.issued2013-04-11
dc.identifier.urihttp://hdl.handle.net/10464/4284
dc.description.abstractThis study examined patterns of psychotropic medication use among 120 participants with intellectual disabilities (ID) who used to live in facilities and now reside in community-based settings in Ontario. There were significantly more participants taking psychotropic medication in the community (83.30/0) than in the facility (74.2%). Of those who showed change, 4.2% were taking medication in the facility but not in the community, and 13.3% were taking medications in the community but not in the facility. While significantly more participants in the community were taking antipsychotic and antidepressant medications, there was no significant increase in psychiatric diagnoses after relocation. Additionally, PRN use was significantly reduced in the comlnunity while daily medication use was significantly higher. The most common PRN in both settings was lorazepam and the most common antipsychotics were risperidone, quetiapine and olanzapine.en_US
dc.subjectPeople with intellectual disabilitiesen_US
dc.subjectPsychotropic medication useen_US
dc.titleA Description of Psychotropic Medication Use in Institution and Community Settings in Ontario.en_US
dc.degree.nameM.A. Applied Disability Studiesen_US
dc.degree.levelMastersen_US
dc.contributor.departmentCenter for Applied Disability Studiesen_US
dc.degree.disciplineFaculty of Social Sciencesen_US
dc.embargo.termsNoneen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record